Home Compare ABT vs GEHC
Stock Comparison · Industry comparison · Medical Devices

Abbott Laboratories vs GE HealthCare Technologies: Which Stock Looks Stronger in 2026?

The structural profiles are close, with GE HealthCare Technologies carrying a narrow edge on stability. Abbott Laboratories still has the edge on stability, which keeps the comparison from looking entirely one-sided. Both sides have seen trend damage — neither carries a clear market edge right now. With both trends damaged, the structural comparison carries most of the weight here.

The comparison is based on similar long-term financial trajectories, not sector labels.

Updated 2026-04-05

On stability, the clearer edge sits with Abbott Laboratories, while the overall score remains tighter and points the other way.

INDUSTRY COMPARISON

Both operate in: Medical Devices

This comparison is based on industry proximity, not on functional trajectory similarity. ABT and GEHC share the same industry classification.

For a similarity-based comparison, see how Abbott Laboratories and GEHC each position within their functional peer groups in AssetNext.

Peer-Relative Score
ABT
Abbott Laboratories
53
Peer-Score
Signal qualityHigh
vs
GEHC
GE HealthCare Technologies Inc.
54
Peer-Score
Signal qualityHigh

Scores reflect position relative to comparable companies with similar long-term financial trajectories.

The clearest separation appears in stability.

Dimension spread: ABT vs GEHC Profitability 59 50 Stability 80 41 Valuation 66 88 Growth 0 22 ABT GEHC
Gap Ranking
#1 Stability +39
#2 Growth +22
#3 Valuation +22
#4 Profitability +9
Price Setup

Left means cheaper relative valuation. Higher means stronger structure.

Price setup map for ABT and GEHC Stronger + cheaper Stronger + richer Weaker + cheaper Weaker + richer ABTGEHC Relative valuation Structural strength

The setup splits cleanly: structure favours Abbott Laboratories, while the price setup favours GE HealthCare Technologies Inc..

Valuation position uses peer-relative PE percentile (idx_pct_pe) where available.

Relative Position vs Comparable Companies
Stability
Both profiles are strong on stability, but Abbott Laboratories leads clearly.
Growth
Neither side looks especially strong on growth, though Abbott Laboratories still ranks somewhat higher.
Stability — Dominant Gap
ABT
80
GEHC
41
Gap+39in favour of ABT

The stability gap is wide, with the stronger side looking materially steadier through time.

What keeps the gap from being one-sided

Abbott Laboratories still looks less cycle-sensitive — that keeps the result from looking completely one-sided.

What this means for the comparison

Stability is the clearest driver of the lead, with growth adding further support — though stability still provides a real counterweight.

Explore full peer positioning in AssetNext

Break down the ABT vs GEHC comparison across all dimensions with the full interactive tool.

Explore full breakdown →
Other comparisons with conflicting dimension signals

Explore how ABT and GEHC each compare against other companies in their peer groups.

Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.

How AssetNext Peer Scores Work

AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.

Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.

Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.